Atea Pharmaceuticals, Inc. Operating Lease, Liability, Current
Atea Pharmaceuticals, Inc. (AVIR) had Operating Lease, Liability, Current of $424.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $424.00K.
- 2026-03-31: Operating Lease, Liability, Current $634.00K.
- 2025-12-31: Operating Lease, Liability, Current $843.00K.
- 2025-09-30: Operating Lease, Liability, Current $832.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $424.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $634.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $843.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $832.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $821.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $811.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $800.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $790.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $780.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $769.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $760.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $750.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $740.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $730.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $721.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $711.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $730.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $113.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $197.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $279.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $332.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $323.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |